NCT03386708View on ClinicalTrials.gov

hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

September 21, 2021

Conditions
Uterus; Injury
Interventions
PROCEDURE

intrauterine injection

intrauterine injection with umbilical cord mesenchymal stem cell (SCLnow 19#); one time/one menstrual cycle, total 2 times

BIOLOGICAL

human umbilical cord mesenchymal stem cell

2 \* 10\^7 cells (2ml)

Trial Locations (1)

410008

Xiangya Hospital Central South University, Changsha

All Listed Sponsors
lead

Sclnow Biotechnology Co., Ltd.

INDUSTRY

NCT03386708 - hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury | Biotech Hunter | Biotech Hunter